Anti-oxidant activity of 1-(1H-imidazo[4,5-c]pyridin-4-yl)ethenone, a Maillard reaction product derived from fructose and histidine

被引:0
|
作者
Zhao, Kangyu [1 ]
Long, Xin [1 ]
Li, Junle [1 ]
Wang, Ying [1 ]
Lan, Ping [1 ]
Wang, Yong [1 ]
机构
[1] Jinan Univ, Guangdong Joint Int Res Ctr Oilseed Biorefinery Nu, Dept Food Sci & Engn, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
antioxidant activity; fructose; histidine; Maillard reaction products; quantum chemical calculation; molecular docking; MODEL; INHIBITION;
D O I
10.1002/jsfa.13779
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
BACKGROUND: The Maillard reaction involves the interaction of various amino acids and reducing sugars, resulting in food browning. It often produces appealing aromas and flavors. The complexities of the reaction are such that it can be challenging to identify the often numerous and frequently volatile products formed by it. In the present study, we sought to identify and evaluate an unusual product with anti-oxidant activity arising from a fructose-histidine Maillard reaction model. The anti-oxidant profile of this product was assessed by computational means. RESULTS: The fructose-histidine Maillard reaction products (FH-MRPs) were generated by heating a 2:1 mixture of the sugar and the amino acid at 140 degrees C for 2 h. Chromatographically separable fractions, labelled DM-1 to DM-8, were obtained using silica gel as the stationary phase and dichloromethane/methanol (DCM/MeOH) mixtures as the mobile one. Fraction DM-5 exhibited the highest 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity, and further bio-assay guided fractionation led to isolation and identification of 1-(1H-imidazo[4,5-c]pyridin-4-yl)ethenone (IMPE) as the active principal, the structure of which was established by nuclear magnetic resonance (NMR) spectroscopic and mass spectral techniques. A mechanism for the formation of IMPE from its precursors is proposed. Density functional theory (DFT) calculations suggest this novel heterocyclic compound exerts its anti-oxidant effects by interacting with DPPH and 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radicals. Essentially, IMPE was non-toxic below 300 ug mL(-1), showing a concentration-dependent free radical clearance capacity and reducing power within the 100-1000 mu g mL(-1) range, and moreover, exhibiting significant Fe2+ chelating abilities wihin the 50-200 mu g mL(-1) range. CONCLUSION: This study identified the unique FH-MRP, IMPE, and found that it acts as food antioxidant through the chelation of metal ions. (c) 2024 Society of Chemical Industry.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] NEW BRONCHODILATORS .1. 1,5-SUBSTITUTED 1H-IMIDAZO[4,5-C]QUINOLIN-4(5H)-ONES
    SUZUKI, F
    KURODA, T
    NAKASATO, Y
    MANABE, H
    OHMORI, K
    KITAMURA, S
    ICHIKAWA, S
    OHNO, T
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (22) : 4045 - 4053
  • [22] The synthesis of anti-fixed 7-methyl-1-b-D-deoxyribofuranosyl-1H-imidazo [4,5-c] pyridin-4-ylamime.
    Nofar, J
    Lucia, JS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U154 - U154
  • [23] SYNTHETIC STUDIES OF POTENTIAL ANTIMETABOLITES .12. SYNTHESIS OF 4-SUBSTITUTED 1-(BETA-D-RIBOFURANOSYL)-1H-IMIDAZO[4,5-C]PYRIDINES
    MIZUNO, Y
    TAZAWA, S
    KAGEURA, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1968, 16 (10) : 2011 - +
  • [24] Ground and excited state prototropism in 2-(2′-methoxyphenyl)1H-imidazo[4,5-c]pyridine
    Balamurali, MM
    Dogra, SK
    JOURNAL OF MOLECULAR STRUCTURE, 2004, 691 (1-3) : 59 - 70
  • [25] (1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives:: Further optimisation as highly potent and selective MSK-1-inhibitors
    Bamford, MJ
    Bailey, N
    Davies, S
    Dean, DK
    Francis, L
    Panchal, TA
    Parr, CA
    Sehmi, S
    Steadman, JG
    Takle, AK
    Townsend, JT
    Wilson, DM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (14) : 3407 - 3411
  • [26] Crystal structure of 1-(thiazolo[4,5-c]pyridin-2-yl)hydrazine, C6H6N4S
    Zhang, Yu
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2014, 229 (03): : 231 - 232
  • [27] Evaluation of N-(phenylmethyl)-4-[5-(phenylmethyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-4-yl]benzamide inhibitors of Mycobacterium tuberculosis growth
    Wall, Michael D.
    Oshin, Michael
    Chung, Gavin A. C.
    Parkhouse, Tony
    Gore, Andrea
    Herreros, Esperanza
    Cox, Brian
    Duncan, Ken
    Evans, Brian
    Everett, Martin
    Mendoza, Alfonso
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (10) : 2740 - 2744
  • [28] Synthesis, Characterization, and Biological Activity of 1-(Pyridin-4-yl)-1H-pyrazol-5-amine Derivatives
    P. A. Rechel
    S. Jyothi
    Russian Journal of Organic Chemistry, 2024, 60 (12) : 2417 - 2421
  • [29] 3-[(1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-yl)amino]benzoic acid
    Fun, Hoong-Kun
    Shahani, Tara
    Dinesh
    Kayarmar, Reshma
    Nagaraja, G. K.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2150 - U1553
  • [30] Crystal structure of (1E)-1-isobutyl-4-(2-(1-phenylethylidene) hydrazinyl)-1H-imidazo[4,5-c] quinolon
    Prathap, Chethan K. N.
    Naveen, S.
    Lokanath, N. K.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2017, 73 : C482 - C482